Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma leptin is not associated with prostate cancer risk.

Literature DB >> 12750247

Plasma leptin is not associated with prostate cancer risk.

Pär Stattin¹, Rudolf Kaaks, Robert Johansson, Randi Gislefoss, Stefan Söderberg, Henrik Alfthan, Ulf-Håkan Stenman, Egil Jellum, Tommy Olsson.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Leptin

Year: 2003 PMID： 12750247

Source DB: PubMed Journal: Cancer Epidemiol Biomarkers Prev ISSN： 1055-9965 Impact factor: 4.254

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors: Marian L Neuhouser; Cathee Till; Alan Kristal; Phyllis Goodman; Ashraful Hoque; Elizabeth A Platz; Ann W Hsing; Demetrius Albanes; Howard L Parnes; Michael Pollak
Journal: Cancer Prev Res (Phila) Date: 2010-02-23

2. Potential role of leptin expression in hepatocellular carcinoma.

Authors: S-N Wang; Y-T Yeh; S-F Yang; C-Y Chai; K-T Lee
Journal: J Clin Pathol Date: 2006-03-24 Impact factor: 3.411

3. Examining the relationship between obesity and prostate cancer.

Authors: Stephen J Freedland; William J Aronson
Journal: Rev Urol Date: 2004

4. Metabolic imbalance and prostate cancer progression.

Authors: Anya J Burton; Kate M Tilling; Jeff M Holly; Freddie C Hamdy; Mari-Anne E Rowlands; Jenny L Donovan; Richard M Martin
Journal: Int J Mol Epidemiol Genet Date: 2010-07-25

5. Racial variation in umbilical cord blood leptin concentration in male babies.

Authors: Gabriel Y Lai; Sabine Rohrmann; Tanya Agurs-Collins; Catherine G Sutcliffe; Gary Bradwin; Nader Rifai; Jessica L Bienstock; Elizabeth A Platz
Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-02-09 Impact factor: 4.254

6. Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Authors: Jay H Fowke; Saundra Motley; Qi Dai; Raoul Concepcion; Daniel A Barocas
Journal: Cancer Lett Date: 2012-10-16 Impact factor: 8.679

Plasma leptin is not associated with prostate cancer risk.

1. Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

2. Potential role of leptin expression in hepatocellular carcinoma.

3. Examining the relationship between obesity and prostate cancer.

4. Metabolic imbalance and prostate cancer progression.

5. Racial variation in umbilical cord blood leptin concentration in male babies.

6. Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

7. Adipokine genes and prostate cancer risk.

Review 8. The impact of obesity on prostate cancer.

9. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.

10. Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.